The use of the RESPeRATE device to lower blood pressure in inner city obese adolescents and children: a pilot feasibility study.

Melvin B Heyman, Janet M Wojcicki, Jillian D Geissler, Christina W Stokes, C T Tran

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2014;20(2):89-92

PMID: 23653175

Abstract

The RESPeRATE device was tested for feasibility of use in a population of overweight and obese children and adolescents (n = 10) in San Francisco, CA. After a 2-week and then a 2-month period, participants were interviewed on their frequency of use and attitudes towards the device. A high percentage stated that they enjoyed using the device at 2 months (90%) and 80% stated that they would recommend use to a friend or relative. Future studies are needed to assess the efficacy of the RESPeRATE device in lowering blood pressure and helping with weight loss/weight management in obese and overweight children.

Address: Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94134, USA. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.